Login / Signup
When should gene therapy be considered for transfusion-dependent β-thalassemia patients?
Cheryl Mensah
Sujit Sheth
Published in:
Hematology. American Society of Hematology. Education Program (2023)
Keyphrases
</>
gene therapy
end stage renal disease
ejection fraction
newly diagnosed
prognostic factors
sickle cell disease
acute kidney injury
patient reported